-
1
pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy
Published 2022-05-01“…Recent phase II and III trials have shown that Pitolisant helps reduce the ESS score and cataplexy. …”
Get full text
Article -
2
Narcolepsy treatment: from exorcism and bloodletting to modern therapy with histamine receptor inverse agonists
Published 2020-09-01Subjects: Get full text
Article